Pseudoefedrin je simpatomimetik iz hemijskih klasa fenetilamina i amfetamina. On se može koristiti kao nazalni/sinusni dekongestiv, a i kao stimulans.[7]

Pseudoefedrin
(IUPAC) ime
(S,S)-2-metilamino-1-fenilpropan-1-ol
Klinički podaci
Robne marke Afrinol, Sudafed, Sinutab (UK)
AHFS/Drugs.com Monografija
MedlinePlus a682619
Identifikatori
CAS broj 90-82-4
ATC kod R01BA02
PubChem[1][2] 7028
DrugBank DB00852
ChemSpider[3] 6761
UNII 7CUC9DDI9F DaY
KEGG[4] D08449 DaY
ChEBI CHEBI:51209 DaY
ChEMBL[5] CHEMBL1590 DaY
Hemijski podaci
Formula C10H15NO 
Mol. masa 165,23
SMILES eMolekuli & PubHem
Farmakokinetički podaci
Bioraspoloživost ~100%[6]
Metabolizam hepatički (10–30%)
Poluvreme eliminacije 4,3–8 sata[6]
Izlučivanje 43–96% renalno[6]
Farmakoinformacioni podaci
Trudnoća B2(AU) C(US)
Pravni status Samo uz dozvolu apotekara (S3) (AU) ? (CA) P (UK) OTC (SAD)
Način primene oralno

Soli pseudoefedrin hidrohlorid i pseudoefedrin sulfat su prisutne u mnogim preparatima na slobodno, bilo kao jedini sastojak, ili u kombinaciji sa antihistaminicima, guaifenezinom, dekstrometorfanom, paracetamolom (acetaminofenom), ili NSAID (kao što je aspirin ili ibuprofen).

Hemija

uredi

Pseudoefedrin je dijastereoizomer efedrina i lako se redukuje u metamfetamin, ili oksiduje u metkatinon.

 
Dva para enantiomera: efedrin (gore) i pseudoefedrin (dole)

Reference

uredi
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  5. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  6. 6,0 6,1 6,2 Laurence L Brunton, ur. (2006). Goodman & Gilman's The Pharmacological Basis of Therapeutics (11th izd.). New York: McGraw-Hill Medical Publishing Division. ISBN 0-07-142280-3. 
  7. Hunter Gillies, Wayne E. Derman, Timothy D. Noakes, Peter Smith, Alicia Evans, and Gary Gabriels (1996-12-01). „Pseudoephedrine is without ergogenic effects during prolonged exercise”. Journal of Applied Physiology 81: 2611-2617. Arhivirano iz originala na datum 2017-06-19. Pristupljeno 2013-09-29. 

Povezano

uredi
pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy